...
首页> 外文期刊>Nuclear Medicine Communications >A correlation study between maximum standardized uptake values and pathology and clinical staging in nonsmall cell lung cancer.
【24h】

A correlation study between maximum standardized uptake values and pathology and clinical staging in nonsmall cell lung cancer.

机译:非小细胞肺癌最大标准化摄取值与病理学和临床分期之间的相关性研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To investigate the relationship between maximum standardized uptake value and pathological type, degree of differentiation, tumor size, and clinical staging of nonsmall cell lung cancer (NSCLC). METHODS: This study included 135 cases with pathologically proven NSCLC. Correlations between maximum standardized uptake value (SUVmax) and pathological type, degree of differentiation, tumor size, and clinical staging were analyzed. RESULTS: There was a significant correlation between the SUVmax of NSCLC and the pathological type (r= 0.391, P= 0.000); the SUVmax of squamous cell carcinoma (SCC) was higher than that of adenocarcinoma (AC) (P =0.000), and the SUVmax of AC was higher than that of bronchioloalveolar carcinoma (P = 0.004). There was a positive correlation between the SUVmax of AC and the degree of differentiation (r= 0.222, P = 0.044); SUVmax was lower in well-differentiated ACs than in moderately or poorly differentiated ACs (P=0.034 and 0.022 respectively); however, there was no statistical difference between the moderately differentiated and poorly differentiated groups (P= 1.000). There was no correlation between the SUVmax of SCC and the degree of differentiation (r= - 0.304, P= 0.054). A positive correlation was found between the SUVmax of NSCLC and tumor size (r= 0.569, P =0.000). The SUVmax of AC had a positive correlation with clinical staging (r= 0.298, P = 0.006); SUVmax was lower in stage I than in stages II, III, and IV (P = 0.047, 0.038 and 0.015, respectively); however, the SUVmax in stages II, III, and IV were not different (P= 0.708, 0.570 and 0.528, respectively). There was no correlation between the SUVmax of SCC and clinical staging (r =0.066, P = 0.680). CONCLUSION: There was a correlation between the SUVmax of NSCLC and the pathological type and tumor size. A positive correlation was found between the SUVmax of AC and the degree of differentiation and clinical staging. There were no correlations between the SUVmax of SCC and the degree of differentiation or clinical staging.
机译:目的:探讨最大标准摄取值与非小细胞肺癌(NSCLC)的病理类型,分化程度,肿瘤大小和临床分期之间的关系。方法:本研究包括135例经病理证实的NSCLC。分析了最大标准摄取值(SUVmax)与病理类型,分化程度,肿瘤大小和临床分期之间的相关性。结果:NSCLC的SUVmax与病理类型之间存在显着相关性(r = 0.391,P = 0.000)。鳞状细胞癌(SCC)的SUVmax高于腺癌(AC)(P = 0.000),AC的SUVmax高于支气管肺泡癌(P = 0.004)。 AC的SUVmax与分化程度之间呈正相关(r = 0.222,P = 0.044)。高分化AC中的SUVmax低于中分化AC中的SUVmax(分别为P = 0.034和0.022)。然而,中分化组和低分化组之间无统计学差异(P = 1.000)。 SCC的SUVmax与分化程度之间无相关性(r =-0.304,P = 0.054)。 NSCLC的SUVmax与肿瘤大小呈正相关(r = 0.569,P = 0.000)。 AC的SUVmax与临床分期呈正相关(r = 0.298,P = 0.006)。第一阶段的SUVmax低于第二阶段,第三阶段和第四阶段(分别为P = 0.047、0.038和0.015);然而,阶段II,III和IV的SUVmax没有差异(分别为P = 0.708、0.570和0.528)。 SCC的SUVmax与临床分期之间无相关性(r = 0.066,P = 0.680)。结论:NSCLC的SUVmax与病理类型和肿瘤大小有关。在AC的SUVmax与分化程度和临床分期之间发现正相关。 SCC的SUVmax与分化程度或临床分期之间没有相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号